Putting Patients First Blog

JUNE 16, 2025

For example, incorporating immunization registries, social service data, and SDOH risk factors from trusted third-party sources would support holistic patient engagement tools. Developers would benefit from complementary integration with public sources such as the Area Deprivation Index and immunization registries.

Documentation 52

Documentation Communication Immunity Immunization 52

Pharmacy Times

JULY 9, 2025

As evidence evolves, pharmacists can lead in translating research into practice—implementing screening, personalized dosing, and interprofessional coordination while awaiting definitive trial results. 1-4 REFERENCES 1. Jiang Y, Dang W, Sui L, et al. Associations Between Vitamin D and Core Symptoms in ASD: An umbrella review. 2024;16:59–91.

Pharmacy Technician 40

Pharmacy Technician Compounding Pharmacies Pharmacy Management Diabetes 40

Pharmacy Times

JUNE 12, 2025

1,2 The primary end point was event-free survival (EFS), which was defined as the time from randomization to the first occurrence of disease progression precluding definitive surgery, local or distant disease progression or recurrence, or death due to any cause. The key secondary end point was overall survival (OS). months (95% CI: 37.9,

Pharmacy Technician 32

Pharmacy Technician Compounding Pharmacies Pharmacy Management Diabetes 32

Pharmacy Times

JUNE 6, 2025

Klein: In terms of the management of pericarditis and recurrent pericarditis, let me just go through definitions. Are there specific comorbidities or patient characteristics that influence your decision? Acute pericarditis is the inflammation of the lining of the heart.

Pharmacy Technician 26

Pharmacy Technician Specialty Pharmacies Diabetes Compounding Pharmacies 26

FDA Law Blog: Biosimilars

NOVEMBER 18, 2024

Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization , Lancet 2024; 403: 2307-16. CDRH’s long-standing definition of “valid scientific evidence” does not include opinions or beliefs. Andrew J Shattock et al., The potential consequences could be severe.

Vaccines 116

Vaccines Immunity Immunization 116

pharmaphorum

JULY 17, 2025

This industry-definitive, inflammasome-focused forum is your golden ticket to join and network with 70+ C-Levels, Vice Presidents, and Scientific Leaders across immunology, translational research, biomarker strategy, and clinical development – all under one roof – with the shared mission of advancing inflammasome-targeted therapies.

Immunity 52

Immunity Immunization Diabetes Pharmaceutical Companies 52

STAT

JANUARY 18, 2024

Not knowing what triggers its persistent and distressing symptoms makes the condition challenging to treat; it’s hard to even say definitively who has it. Long Covid has long eluded scientists looking for its cause.

Immunity 363

Immunity Immunization 363

STAT

JUNE 8, 2023

In a 1975 paper, published in Science , Hayes and his colleagues definitively established that taurine deficiency was to blame for retinal degeneration in cats, a landmark discovery that forever changed feline nutrition and eventually launched the Garfield-endorsed Alpo cat food. Continue to STAT+ to read the full story…

Immunity 246

Immunity Immunization 246

Pharmafile

APRIL 11, 2024

Vertex Pharmaceuticals and Alpine Immune Sciences have announced that they have entered into a definitive agreement under which Vertex will acquire Alpine for $65 per share, totaling an approximate $4.9bn. Alpine’s lead […] The post Vertex to acquire Alpine Immune Sciences for $4.9bn appeared first on Pharmafile.

Immunity 59

Immunity Immunization 59

pharmaphorum

DECEMBER 4, 2020

The 4 th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. This is the industry’s definitive antigen specific drug development forum.

Immunity 52

Immunity Immunization Medical Schools Drug Development 52

Express Pharma

APRIL 17, 2023

Merck, known as MSD outside the US and Canada, and Prometheus Biosciences announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8

Immunity 98

Immunity Immunization Research Laboratories Labelling 98

ALiEM - Pharm Pearls

DECEMBER 18, 2023

The regiSCAR diagnostic criteria is the most used diagnostic criteria and is based on a scoring system for possible, probable, or definite diagnosis. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System. Case Question: How should this condition be managed? Int J Mol Sci.

Immunity 177

Immunity Immunization 177

Express Pharma

DECEMBER 26, 2023

AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies, a global clinical-stage biopharma company developing innovative cell therapies for the treatment of cancer and autoimmune diseases. Future applications of this technology may also include rare diseases.” per ordinary share (equivalent to $1.50

Immunity 105

Immunity Immunization 105

Pharmaceutical Technology

APRIL 17, 2023

Merck has signed a definitive agreement to buy clinical-stage biotechnology firm Prometheus Biosciences for $10.8bn, strengthening its immunology pipeline. Prometheus Biosciences uses precision medicine to discover, develop and commercialise new therapeutic and companion diagnostic products to treat immune-mediated diseases.

Immunity 105

Immunity Immunization 105

ALiEM - Pharm Pearls

MARCH 29, 2023

Well-appearing febrile infants The AAP acknowledges that clinician experience is likely the best determinate of what is “well-appearing”, further admitting that there is no measure or definition of either “experience” or “well-appearing” Febrile Rectal temperatures of 38.0C

Hospitals 360

Hospitals Documentation Inpatient Immunity 360

Pharmaceutical Technology

SEPTEMBER 8, 2022

Roche has signed a definitive merger agreement for the acquisition of US-based biopharmaceutical company Good Therapeutics for an upfront payment of $250m in cash. Good Therapeutics focuses on the development of PD-1-regulated IL-2 drugs that are based on innovative conditionally active drug technology.

Immunity 111

Immunity Immunization 111

pharmaphorum

APRIL 12, 2021

This is the definitive drug development forum for research teams to investigate how to modulate the cGAS-STING and Toll-like receptor (7/8/9) pathways both as monotherapies and as adjuvants in combinatorial approaches. View the full event guide now. The post STING & TLR Targeting Therapies Summit appeared first on.

Immunity 52

Immunity Immunization Drug Development 52

Pharmaceutical Technology

AUGUST 5, 2022

Gilead Sciences has signed a definitive agreement for the acquisition of the complete outstanding share capital of MiroBio in a deal valued at nearly $405m in cash, subject to necessary adjustments. With the acquisition, Gilead will gain access to the discovery platform and complete line of immune inhibitory receptor agonists of MiroBio.

Immunity 52

Immunity Immunization 52

The Thyroid Pharmacist

JUNE 30, 2023

However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. These include Crohn’s, MS, and Hashimoto’s, as well as other immune system-related conditions such as cancer and HIV/AIDS. Doses of 1.5-4.5

Compounding 98

Compounding Immunity Immunization Compounding Pharmacies 98

pharmaphorum

OCTOBER 23, 2020

Anita de Waard from Elsevier and Radoslav Kirkov from Estafet tells us how a hackathon is harnessing data science to look beyond the hype and seek definitive clinical evidence. how long does the immunity from BCG last after that vaccination? Does the strain of BCG vaccination impact immunity? For example.

Vaccines 110

Vaccines Immunity Immunization Hospitals 110

pharmaphorum

APRIL 16, 2021

The 2 nd Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate. Join your peers online and discover: How Chameleon Bioscience are developing an immune evasive AAV for repeat dosing.

Immunity 52

Immunity Immunization 52

Pharmaceutical Technology

NOVEMBER 15, 2022

Jnana Therapeutics and Roche have signed a second partnership and licence agreement to discover small-molecule drugs to treat cancer, immune-mediated and neurological ailments. Jnana will conduct discovery and preclinical works against various cancer, immune-mediated and neurological ailment targets.

Immunity 52

Immunity Immunization 52

pharmaphorum

SEPTEMBER 16, 2020

Regeneron hopes that RECOVERY will provide definitive data about REGN-COV2 and its impact on mortality, hospital stays and the need for ventilation. Regeneron tested thousands of antibodies produced in mice modified to have a human immune system, as well as antibodies identified from people who have recovered from COVID-19.

Hospitals 98

Hospitals Labelling Immunity Immunization 98

pharmaphorum

NOVEMBER 15, 2021

Arriving at a critical point for TIGIT development, the 2nd Annual TIGIT Therapies Summit is the definitive industry-led event focused on propelling this next-generation inhibitor to clinical use. Plus 2 add on workshops: • Elucidating the anti-tumor immunity of other immune checkpoint inhibitors in oncology.

Medical Schools 52

Medical Schools Immunity Immunization Hospitals 52

FADIC

OCTOBER 20, 2023

Vitamin A Role of Vitamin A : Vitamin A has many vital functions in your body: It strengthens your immune system. It helps your muscles move and supports your immune system. ‌ Vitamin E Role of Vitamin E : Vitamin E supports your immune system and prevents blood clots. It’s essential for your vision.

Immunity 82

Immunity Immunization Dosage Patient Counseling 82

Pharmaceutical Technology

JUNE 24, 2022

invoX Pharma has signed a definitive agreement for the acquisition of all issued and outstanding shares of clinical-stage biopharma firm F-star Therapeutics, in a deal valued at nearly $161m or $7.12 for each share in cash. invoX Pharma is a fully owned Sino Biopharmaceutical subsidiary.

Immunity 64

Immunity Immunization 64

Pharmaceutical Technology

MAY 25, 2023

Pyxis Oncology has made a definitive agreement to buy biopharmaceutical company Apexigen, in a deal valued at nearly $16m. Apexigen discovers and develops a new generation of antibody therapeutics to treat cancer, along with new immuno-oncology products to harness the immune system to combat and eradicate cancer.

Immunity 52

Immunity Immunization 52

Pharmaceutical Technology

JUNE 19, 2023

Coherus BioSciences has signed a definitive merger agreement to buy clinical-stage immuno-oncology (I-O) company Surface Oncology, in a deal valued at $65m. The company will buy all outstanding Surface Oncology shares at a price of $5.2831 per share, totalling approximately $40m, along with anticipated net cash of between $20 and $25m.

Biosimilars 52

Biosimilars Immunity Immunization 52

Pharmaceutical Technology

MARCH 30, 2023

The combination therapy has also been indicated for patients who do not have EGFR, ALK or ROS1 aberrations and whose tumours are metastatic or locally advanced, and for those who are not candidates for definitive chemoradiation.

Chemotherapy 52

Chemotherapy Immunity Immunization 52

pharmaphorum

APRIL 20, 2021

The Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit is the definitive industry-led forum for drug development in the largest solid tumor indication.

Drug Development 52

Drug Development Medical Schools Immunity Immunization 52

Pharmaceutical Technology

SEPTEMBER 22, 2022

Sesen Bio has signed a definitive merger agreement to combine its business with Carisma Therapeutics and create a clinical-stage biotechnology firm in an all-stock deal. . Its CAR-M platform offers the potential to modify the specific targets of immune cells, thereby facilitating several therapeutic applications in oncology and beyond. .

Immunity 52

Immunity Immunization 52

pharmaphorum

MARCH 29, 2021

We are even at a point where some cancer medicines are created for each individual patient using their own immune system. By definition they have smaller populations and, therefore, smaller evidence basis. With this increased targeting has come huge increases in effectiveness.”.

Drug Development 93

Drug Development Immunity Immunization 93

pharmaphorum

OCTOBER 16, 2020

By definition, however, trial master files represent a much richer and more detailed source of data on a drug and how it performs. In 2020, the pharmaceutical industry has not by any means proved immune to the disruption caused by COVID-19.

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies Immunity 105

The Thyroid Pharmacist

OCTOBER 7, 2022

I knew he was right — sugar can contribute to a yeast overgrowth, lowered immunity, blood sugar issues, weight gain, diabetes, and a whole host of health problems (1-3) — but I was a sugar addict, and it was devastating to think that I would have to let go of this old friend and not have any sweetness in my life. An in vitro study.

Diabetes 98

Diabetes Immunity Immunization Labelling 98

Board Vitals - Pharmacist

JULY 3, 2024

In addition to practice questions, you should definitely check out the complimentary exam prep videos and documents offered by the ABFM. As an optional add-on, earn up to 100 AAFP Prescribed Credits and up to 40 AMA PRA Category 1 Credits while you study. Want to check it out?

Documentation 52

Documentation Immunity Immunization 52

pharmaphorum

APRIL 28, 2022

Although they have, by definition, small addressable markets, the treatments cost just as many resources to develop as therapies for more common diseases – sometimes more, because of the added difficulty of finding sufficiently large patient populations for trials and finding disease experts to run them.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Immunity Immunization 59

The Thyroid Pharmacist

DECEMBER 2, 2022

No one is immune to the ups and downs of life – circumstances change, we experience loss, and the ongoing noise around us can become overwhelming. There is a range of recipes and not just simple salads as previous review suggested (salmon and parsnip fish cakes are definitely a favourite). The gift of life-changing results… . “I

Compounding 97

Compounding Immunity Immunization 97